Drugs / Fluorouracile
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01715363 | Jul 2012 → Jun 2014 | colorectal cancer | Gustave Roussy, Cancer Campus, Grand Paris | Terminated | No outcome recorded |
Also used as a comparator or background therapy in 3 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT04736485 Background | Jun 2021 → Mar 2024 | digestive system carcinoma | Centre Francois Baclesse | Completed | No outcome recorded |
| Phase 2 | NCT02400567 Comparator | Jan 2015 → Jan 2018 | breast cancer | UNICANCER | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00174707 Comparator | Dec 1997 → Dec 2007 | breast neoplasm | Sanofi | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluorouracile | “Fluorouracile 2600 mg/m² 24 h IV infusion on D1” NCT04736485 ↗ |
| Route | Intravenous | “Fluorouracile 2600 mg/m² 24 h IV infusion on D1” NCT04736485 ↗ |